amprenavir

(redirected from 141W94)
Also found in: Dictionary.

amprenavir

 [am-pren´ah-vir]
an HIV protease inhibitor used in the treatment of human immunodeficiency virus (HIV) infection; administered orally.

amprenavir

/am·pren·a·vir/ (am-pren´ah-vir) an HIV protease inhibitor used in the treatment of HIV-1 infection.

amprenavir

an antiviral (protease inhibitor).
indication It is used to treat HIV in combination with other antiretroviral agents.
contraindication Known hypersensitivity prohibits its use.
adverse effects Life-threatening side effects include Stevens-Johnson syndrome and acute hemolytic anemia. Other serious adverse effects include new-onset diabetes, hyperglycemia, and exacerbation of preexisting diabetes mellitus. Common side effects include diarrhea, abdominal pain, nausea, paresthesia, and rash.

amprenavir

A protease inhibitor used with other antiretrovirals for managing HIV-1 (e.g., nelfinavir, indinavir or saquinavir).

Adverse effects
Nausea, vomiting, diarrhoea, headache, perioral paraesthesias, gastric discomfort, rash, hyperglycaemia, diabetes, acute haemolytic anaemia, spontaneous bleeding in haemophiliacs, fat redistribution.

amprenavir

AIDS A protease inhibitor in clinical trials for treating HIV, used in combination with other protease inhibitors–eg, nelfinavir, indinavir, or saquinavir Adverse effects N&V, diarrhea, headache, perioral paresthesias, stomach discomfort, rash; other effects include hyperglycemia, DM, acute hemolytic anemia, spontaneous bleeding in hemophiliacs, and fat redistribution. See AIDS, Combination therapy, HIV, Protease inhibitor.

amprenavir

A protease inhibitor drug used to treat HIV infections. A brand name is Agenerase.